SI20071A - Asimetrična sinteza benzoksazinonov - Google Patents

Asimetrična sinteza benzoksazinonov Download PDF

Info

Publication number
SI20071A
SI20071A SI9720079A SI9720079A SI20071A SI 20071 A SI20071 A SI 20071A SI 9720079 A SI9720079 A SI 9720079A SI 9720079 A SI9720079 A SI 9720079A SI 20071 A SI20071 A SI 20071A
Authority
SI
Slovenia
Prior art keywords
compound
formula
acid
alkyl
preparation
Prior art date
Application number
SI9720079A
Other languages
English (en)
Slovenian (sl)
Inventor
Michael Ernest Pierce
Anusuva CHOUDHURY
Rodney Lawrence RARSONS
Original Assignee
Dupont Pharmaceuticals Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Pharmaceuticals Company filed Critical Dupont Pharmaceuticals Company
Publication of SI20071A publication Critical patent/SI20071A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI9720079A 1996-12-16 1997-12-15 Asimetrična sinteza benzoksazinonov SI20071A (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3298096P 1996-12-16 1996-12-16
US08/838,838 US5932726A (en) 1996-12-16 1997-04-11 Asymmetric synthesis of benzoxazinones
PCT/US1997/022674 WO1998027073A1 (en) 1996-12-16 1997-12-15 Asymmetric synthesis of benzoxazinones

Publications (1)

Publication Number Publication Date
SI20071A true SI20071A (sl) 2000-04-30

Family

ID=26709131

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9720079A SI20071A (sl) 1996-12-16 1997-12-15 Asimetrična sinteza benzoksazinonov

Country Status (27)

Country Link
US (1) US5932726A (cs)
EP (1) EP0944610B1 (cs)
JP (1) JP4232911B2 (cs)
KR (1) KR100498665B1 (cs)
CN (1) CN1075063C (cs)
AT (1) ATE289296T1 (cs)
AU (1) AU750047B2 (cs)
BR (1) BR9714031A (cs)
CA (1) CA2275323C (cs)
CZ (1) CZ297168B6 (cs)
DE (1) DE69732525T2 (cs)
EA (1) EA002987B1 (cs)
EE (1) EE03920B1 (cs)
ES (1) ES2235265T3 (cs)
HR (1) HRP970688A2 (cs)
HU (1) HU225655B1 (cs)
IL (2) IL130684A (cs)
LV (1) LV12432B (cs)
NO (1) NO313236B1 (cs)
NZ (1) NZ336163A (cs)
PL (1) PL192661B1 (cs)
PT (1) PT944610E (cs)
RO (1) RO120844B1 (cs)
SI (1) SI20071A (cs)
SK (1) SK285258B6 (cs)
UA (1) UA66773C2 (cs)
WO (1) WO1998027073A1 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874430A (en) * 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
US6673372B1 (en) 1998-06-11 2004-01-06 Bristol-Myers Squibb Pharma Company Crystalline Efavirenz
TWI326283B (en) * 2002-07-31 2010-06-21 Du Pont Method for preparing fused oxazinones
AU2003248217A1 (en) * 2003-04-04 2004-10-25 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences An amino alcohol ligand and its use in preparation of chiral proparglic tertiary alkohols and tertiary amines via enantioselective additon reaction
EP2313379B1 (en) 2008-05-30 2015-03-11 Emcure Pharmaceuticals Limited Process for the preparation of efavirenz
US8080655B2 (en) * 2009-07-20 2011-12-20 Apotex Pharmachem Inc. Methods of making efavirenz and intermediates thereof
CN101844990B (zh) * 2010-05-27 2013-03-20 浙江沙星医药化工有限公司 中间体4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的合成方法
EP2447255A1 (en) 2010-10-14 2012-05-02 Lonza Ltd. Process for the synthesis of cyclic carbamates
EP2441759A1 (en) * 2010-10-14 2012-04-18 Lonza Ltd. Process for the synthesis of cyclic carbamates
CN102584801B (zh) * 2011-01-06 2015-02-18 中国科学院上海有机化学研究所 Hiv逆转录酶抑制剂依法韦伦类化合物的一锅法不对称合成工艺
WO2015118515A1 (en) * 2014-02-10 2015-08-13 Discovery Intermediates Private Limited An improved process for the preparation of a non-nucleoside reverse transcriptase inhibitor
EP2944631A1 (en) * 2014-05-12 2015-11-18 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Improved process for the preparation of Efavirenz
CN104016936B (zh) * 2014-06-18 2016-08-17 中国科学院上海有机化学研究所 手性氨基酚配体在依法韦仑不对称合成中的应用
CN105801442A (zh) * 2015-10-16 2016-07-27 浙江沙星医药化工有限公司 4-氯-2-(三氟乙酰基)苯胺盐酸盐水合物的制备方法
JP6268564B2 (ja) * 2015-12-08 2018-01-31 Dic株式会社 オキサジン化合物、組成物及び硬化物
CN108368216B (zh) * 2015-12-08 2020-09-18 Dic株式会社 恶嗪化合物、组合物及固化物
WO2017098926A1 (ja) * 2015-12-08 2017-06-15 Dic株式会社 オキサジン化合物、組成物及び硬化物
NL2018412B1 (en) * 2017-02-23 2018-09-17 Univ Nelson Mandela Metropolitan Method for the manufacture of efavirenz

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE343057C (de) * 1914-06-21 1921-10-25 Kalle & Co Aktien Ges Verfahren zur Darstellung von 1-Arylamino-4-oxynaphthalinen
US3280120A (en) * 1964-03-09 1966-10-18 Rexall Drug Chemical Substituted benzoxazines, process therefor and intermediates
US3526621A (en) * 1966-08-03 1970-09-01 Farmaceutical Italia Soc Substituted 3,1-benzoxazin-2-one
US3513166A (en) * 1967-05-22 1970-05-19 Robins Co Inc A H 3-(omega-aminoalkyl)-4-substituted-1,3-benzoxazine-2-ones
AU5960380A (en) * 1979-08-30 1981-03-05 A. Ehrenreich G.m.b.H. & Co. KG Bellows seal and retaining ring
DE3622262A1 (de) * 1986-07-02 1988-01-07 Bayer Ag Chromogene 3,1-benzoxazine
JPH0436252A (ja) * 1990-05-30 1992-02-06 Nippon Alkyl Alum Kk 光学活性アルキニルアルコールの製造方法
US5663169A (en) * 1992-08-07 1997-09-02 Merck & Co., Inc. Benzoxazinones as inhibitors of HIV reverse transcriptase
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
AU1694295A (en) * 1994-01-28 1995-08-15 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
US5663467A (en) * 1995-01-23 1997-09-02 Merck & Co., Inc. Synthesis of cyclopropylacetylene
US5633405A (en) * 1995-05-25 1997-05-27 Merck & Co., Inc. Asymmetric synthesis of (-)-6-chloro-4-cyclopropyl-ethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxanzin-2-one

Also Published As

Publication number Publication date
PT944610E (pt) 2005-04-29
RO120844B1 (ro) 2006-08-30
NZ336163A (en) 2001-04-27
SK80399A3 (en) 2000-03-13
IL130684A (en) 2003-12-10
EE9900243A (et) 1999-12-15
ES2235265T3 (es) 2005-07-01
DE69732525D1 (de) 2005-03-24
CA2275323A1 (en) 1998-06-25
EA002987B1 (ru) 2002-12-26
KR20000057574A (ko) 2000-09-25
EP0944610B1 (en) 2005-02-16
UA66773C2 (uk) 2004-06-15
CZ297168B6 (cs) 2006-09-13
HUP0000168A3 (en) 2001-02-28
WO1998027073A8 (en) 1999-11-04
JP4232911B2 (ja) 2009-03-04
CZ212899A3 (cs) 1999-11-17
DE69732525T2 (de) 2006-01-12
WO1998027073A1 (en) 1998-06-25
NO992914L (no) 1999-06-15
EP0944610A1 (en) 1999-09-29
LV12432A (lv) 2000-02-20
CN1245493A (zh) 2000-02-23
KR100498665B1 (ko) 2005-07-01
IL130684A0 (en) 2000-06-01
CA2275323C (en) 2003-04-08
NO992914D0 (no) 1999-06-15
HUP0000168A2 (hu) 2000-09-28
JP2001507684A (ja) 2001-06-12
SK285258B6 (sk) 2006-10-05
US5932726A (en) 1999-08-03
HRP970688A2 (en) 1998-10-31
EA199900552A1 (ru) 2000-02-28
AU5694498A (en) 1998-07-15
EE03920B1 (et) 2002-12-16
LV12432B (en) 2000-07-20
HU225655B1 (en) 2007-05-29
PL334281A1 (en) 2000-02-14
AU750047B2 (en) 2002-07-11
ATE289296T1 (de) 2005-03-15
PL192661B1 (pl) 2006-11-30
CN1075063C (zh) 2001-11-21
NO313236B1 (no) 2002-09-02
BR9714031A (pt) 2000-05-09

Similar Documents

Publication Publication Date Title
SI20071A (sl) Asimetrična sinteza benzoksazinonov
US6040480A (en) Asymmetric synthesis of benzoxazinones
KR100391870B1 (ko) N-아릴히드록실아민및n-헤타릴히드록실아민의제조방법
CN109456253B (zh) 一种手性诱导合成(s)-3-(4-溴苯基)-哌啶或其盐的方法
JP7453365B2 (ja) 高純度のｎ－（５－メトキシ―２－フェノキシフェニル）メタンスルホンアミド及びその製造方法
CA2627724A1 (en) Process for the preparation of betamimetic benzoxazinone derivatives
LT4646B (lt) Benzoksazinonų asimetrinė sintezė
JP2018108978A (ja) ビオチンの中間体の製造方法、およびビオチンの製造方法
MXPA99008913A (en) Asymmetric synthesis of benzoxazinones via new intermediates
CZ349099A3 (cs) Asymetrické syntézy benzoxazinonů přes nové meziprodukty
JP4032593B2 (ja) ４−アミノテトラヒドロピラン誘導体の製法
JP5981747B2 (ja) アザディールス−アルダー反応用触媒、それを用いたテトラヒドロピリジン化合物の製造方法
MXPA99005410A (es) Sintesis asimetrica de benzoxazinonas

Legal Events

Date Code Title Description
IF Valid on the event date